Global OTC/DTC Infectious Disease Diagnostics Market Report 2022-2026: Sleeping Giant of Over the Counter and Direct to Consumer Diagnostics is Set to Create a Broad New Diagnostic Industry
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct To Consumer. Forecasts by Application by Channel by Country. With Market Analysis, Executive Guides, Customization and Market Opportunity Analysis 2022 to 2026" report has been added to ResearchAndMarkets.com's offering.
The sleeping giant of Over the Counter and Direct to Consumer diagnostics is set to create a broad new diagnostic industry. New technologies create rapid test solutions for the home market. Self-Sampling technology key.
Genetic DTC testing led the way. Now Infectious disease testing is moving directly to the consumer. New sampling technology, and rapid and multiplex tests have changed the picture on how and where testing is done. And the pandemic has proven the need for self-testing. This report explores the DTC outlook for different syndromes. Find out where the action is and learn about the players.
Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even CRISPR diagnostics are now coming into play.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report. The report has hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing.
OTC/DTC Infectious Disease Testing Recent Developments
Startup Detect to Roll Out Next-Gen Molecular Instrument
Diagnostics for the Real World Third-Generation POC Platform
Labcorp Partnering With Getlabs for Home Collection
Salignostics Closes Funding Round
Cue Health Targets DTC Market in 2022
Grip Molecular Developing Home Respiratory Panel
Mainz Biomed Developing Home ColoAlert Assay
MFB Fertility Closes Series A Financing Round
Continued Demand for SARS-CoV-2 Rapid Tests
Rapid Covid-19 Test Results Risk Going Uncounted
FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit
Researchers Develop 15-Minute PCR System
Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test
Lucira Health Files for $115M IPO
Spectrum Solutions Gets CE Mark for Saliva Collection Devices
Sherlock Biosciences Receives Gates Foundation Grant for COVID-19 Self-Test
LabCorp Receives EUA for OTC COVID-19 Test Home Collection Kit
FemtoDx Launches Rapid At-Home Test Development for COVID-19
FDA approves first at-home coronavirus test
Free Home HIV Tests Detect More Infections
Biohacking trend supports self testing.
PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market
Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self-Test
OraSure Technologies, Inc. Announces Two Acquisitions
Nigerian Govt Approves Alere HIV Self-Test Kit
Boots launches UTI test and treat service across 37 branches
Scanwell Health moves beyond home UTI testing
Healthy.io raises $18 million for at-home urinalysis tests
LetsGetChecked collects $30M more for at-home health testing
TestCard, a $4 Urine Test Read by Smartphone
Digital Health Startup EverlyWell Raises $50M
Thriva adds test-at-home kits for female hormone and cortisol stress
Tasso scores $6.1M for patch-based home blood testing
DBS Systems HEMAXIS receives CE/IVD mark
Abbott HbA1c point-of-care test reliably diagnoses diabetes
Industry Overview
Industry Participants
IVD Supplier
Independent lab specialized/esoteric
Independent lab national/regional
Independent lab analytical
Public National/regional lab
Hospital lab
Physician lab
Pharmacies
Audit body
The Clinical Laboratory Market Segments
Traditional Market Segmentation
Laboratory Focus and Segmentation
Segmenting the OTC/DTC Market
Industry Structure
Hospital Testing Share
Economies of Scale
Hospital vs. Central Lab
Physician Office Lab's
The Problem with POLS
Physician's and OCT/DTC
Pharmacies and OCT/DTC
The Diagnostic Plight of Pharmacies - Trying to do good
The Theranos Legacy
Market Trends
Factors Driving Growth
Privacy and Anonymity
The Internet Effect
Rapid Result
The Wellness Movement
The COVID-19 Impact
Factors Limiting Growth
Trust Factor
Infectious Disease is Declining But..
Wellness Hurts
Economic Growth improves Living Standards
Diagnostic Technology Development
The Multiplex Paradigm Shift
NAT vs. Lateral Flow
The Unusual Role of GPS
Self and Send Competition
The Relationship to DTC Genetic
The Relationship to TeleHealth
Sample Collection - Who Knew?
Profiles of Key Diagnostic Testing Companies
1DropDiagnostics
Abbott Laboratories
Ador Diagnostics
ADT Biotech
Akonni Biosystems
Alveo Technologies
Antelope Dx
Applied BioCode
Atomo Diagnostics
Aus Diagnostics
Becton, Dickinson and Company
Binx Health
Biocartis
BioFire Diagnostics (bioMerieux)
bioMerieux Diagnostics
Bio-Rad Laboratories, Inc
Bosch Healthcare Solutions GmbH
Cepheid (Danaher)
Cue Health
Curetis N.V. / Curetis GmbH
DBS Systems
Detect
Diagenode Diagnostics
Diasorin S.p.A.
Ellume
Everywell
Getlabs.
Grip Molecular Technologies
Healthy.io
Hologic
Inflammatix
Invetech
Janssen Diagnostics
Karius
Laboratory Corporation of America
Letsgetchecked
Lexagene
Lucira Health
Luminex Corp
Mbio Diagnostics
Mesa Biotech (Thermo Fisher)
MFB Fertility
Mobidiag (Hologic)
myLabBox
Mylan
Nanomix
OraSure Technologies
Oxford Nanopore Technologies
Panagene
Primerdesign (Novacyt)
Prominex
Qiagen
QuantuMDx
Quest Diagnostics
Quidel
Randox Toxicology
Roche Molecular Diagnostics
Salignostics
Scanwell Health
SD Biosensor
Seegene
Seventh Sense Biosystems.
Siemens Healthineers
T2 Biosystems
TestCard
Thermo Fisher Scientific Inc.
Thriva
Visby Medical
XCR Diagnostics
The Infectious Diseases - Guide to the Pathogens
HIV - Human Immunodeficiency Virus (AIDS)
HBV - Hepatitis B.
HCV - Hepatitis C
HPV - Human papillomavirus
Coronavirus
Influenza
CT/NG - Chlamydia/Gonorhea
UTI
GAS
RESP
For more information about this report visit https://www.researchandmarkets.com/r/cbftwt
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900